Publications, Pharmaceutical

A Pharmapack Europe 2022 Preview: The Future of Medical Devices

The connected device industry has changed significantly over the past years and has many benefits as well as developmental challenges.

Essentially connected devices are either add-ons or integrated and choice is primarily driven by cost and sustainability issues. This interview reviews the evolution of connected devices, strategies for improving patient’s health outcomes and broader issues associated with sustainability. Regulatory approvals, reimbursement as well as real world evidence and Digital Therapeutics are recognised goals but poor patient compliance and adherence, management of personal data and adoption of digital healthcare tools are all highlighted as key contributory factors when it comes to the overall challenges of successful adoption of connected devices.

Read the Interview
Author(s): Marcus Bates
16 May 2022

Learn more about Aptar Pharma’s expertise in Digital Health

Find Out More about Aptar Digital Health

This Might Also Be of Your Interest

5 Jul 2022

Drug, Device, Digital: Reimagined Healthcare

Webinars, Pharmaceutical, Innovation & Insights, Brand Differentiation, Market Insights, Product Solutions

Read More
30 Jun 2022

Supporting Patients and HCPs with New Digital Technology

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
13 Dec 2021

Towards A New Standard of Care with Aptar Pharma’s Digital ...

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
18 Nov 2021

Using digital devices to boost patient outcomes in respiratory he...

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
1 2 3 4
Back To Top